Cargando…
Semaphorin Signaling in Cancer-Associated Inflammation
The inflammatory and immune response elicited by the growth of cancer cells is a major element conditioning the tumor microenvironment, impinging on disease progression and patients’ prognosis. Semaphorin receptors are widely expressed in inflammatory cells, and their ligands are provided by tumor c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358995/ https://www.ncbi.nlm.nih.gov/pubmed/30658382 http://dx.doi.org/10.3390/ijms20020377 |
_version_ | 1783392120924536832 |
---|---|
author | Franzolin, Giulia Tamagnone, Luca |
author_facet | Franzolin, Giulia Tamagnone, Luca |
author_sort | Franzolin, Giulia |
collection | PubMed |
description | The inflammatory and immune response elicited by the growth of cancer cells is a major element conditioning the tumor microenvironment, impinging on disease progression and patients’ prognosis. Semaphorin receptors are widely expressed in inflammatory cells, and their ligands are provided by tumor cells, featuring an intense signaling cross-talk at local and systemic levels. Moreover, diverse semaphorins control both cells of the innate and the antigen-specific immunity. Notably, semaphorin signals acting as inhibitors of anti-cancer immune response are often dysregulated in human tumors, and may represent potential therapeutic targets. In this mini-review, we provide a survey of the best known semaphorin regulators of inflammatory and immune cells, and discuss their functional impact in the tumor microenvironment. |
format | Online Article Text |
id | pubmed-6358995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63589952019-02-06 Semaphorin Signaling in Cancer-Associated Inflammation Franzolin, Giulia Tamagnone, Luca Int J Mol Sci Review The inflammatory and immune response elicited by the growth of cancer cells is a major element conditioning the tumor microenvironment, impinging on disease progression and patients’ prognosis. Semaphorin receptors are widely expressed in inflammatory cells, and their ligands are provided by tumor cells, featuring an intense signaling cross-talk at local and systemic levels. Moreover, diverse semaphorins control both cells of the innate and the antigen-specific immunity. Notably, semaphorin signals acting as inhibitors of anti-cancer immune response are often dysregulated in human tumors, and may represent potential therapeutic targets. In this mini-review, we provide a survey of the best known semaphorin regulators of inflammatory and immune cells, and discuss their functional impact in the tumor microenvironment. MDPI 2019-01-17 /pmc/articles/PMC6358995/ /pubmed/30658382 http://dx.doi.org/10.3390/ijms20020377 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Franzolin, Giulia Tamagnone, Luca Semaphorin Signaling in Cancer-Associated Inflammation |
title | Semaphorin Signaling in Cancer-Associated Inflammation |
title_full | Semaphorin Signaling in Cancer-Associated Inflammation |
title_fullStr | Semaphorin Signaling in Cancer-Associated Inflammation |
title_full_unstemmed | Semaphorin Signaling in Cancer-Associated Inflammation |
title_short | Semaphorin Signaling in Cancer-Associated Inflammation |
title_sort | semaphorin signaling in cancer-associated inflammation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358995/ https://www.ncbi.nlm.nih.gov/pubmed/30658382 http://dx.doi.org/10.3390/ijms20020377 |
work_keys_str_mv | AT franzolingiulia semaphorinsignalingincancerassociatedinflammation AT tamagnoneluca semaphorinsignalingincancerassociatedinflammation |